Troypofol

Indications

• Induction of general anesthesia
• Maintenance of general anesthesia
• Sedation for procedures

Dosage

Children: For children aged 1 month to 16 years, the usual dose for induction of anesthesia is 2.5–4 mg/kg, adjusted according to age, body weight, and response.

Adults: For induction of anesthesia, the usual adult dose is 1.5–2.5 mg/kg administered by slow intravenous injection. For maintenance, a continuous infusion of 4–12 mg/kg/hour may be used.

Mechanism of action

Propofol exerts its anesthetic effects by positively modulating the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at GABA-A receptors, leading to increased inhibitory neurotransmission and resulting in sedation and anesthesia.

Pharmacodynamics

As a sedative-hypnotic agent, propofol rapidly induces hypnosis with minimal excitation, typically within 40 seconds after intravenous administration. This rapid action is due to its high lipid solubility, allowing for quick distribution to the central nervous system. The drug also has a favorable recovery profile, with patients often regaining consciousness shortly after cessation of the infusion.

Pharmacokinetics

Propofol is highly lipophilic, leading to rapid distribution and a short half-life. It is primarily metabolized in the liver via conjugation and oxidation, and excreted in urine, mainly as metabolites. The drug has a volume of distribution of around 4 liters per kilogram, and its clearance is approximately 1.5 liters per minute, which results in a short duration of action.

Contra-indications

• Hypersensitivity to propofol or any of its components
• Severe respiratory depression
• Acute porphyrias
• Acute circulatory failure (shock)
• Adrenal insufficiency

Adverse effects

• Apnea
• Hypotension
• Nausea
• Respiratory disorders
• Skin reactions
• Vascular pain
• Vomiting
• Arrhythmias
• Cough
• Hiccups
• Hypertension
• Muscle rigidity
• Neuromuscular dysfunction
• Nystagmus
• Procedural complications

Interactions

• Valproate may increase propofol concentration
• Active component of sacituzumab govitecan may increase exposure to propofol

Precautions

• Careful monitoring of fluids and electrolytes
• Use with caution in patients with cardiovascular disease
• Elderly patients may require dose adjustment
• Avoid in patients with fixed cardiac output, hypovolaemia, or severe hypotension

Pregnancy

Propofol should be used during pregnancy only if clearly needed and after careful consideration of risks and benefits.

Breast-feeding

Propofol is excreted in breast milk; caution should be exercised when administered to breastfeeding women.

Storage

Store at room temperature, protect from light, and do not freeze.

Formulations

• Emulsion for injection
• 0.5% or 1% injection solution

Indications

• Nutritional supplementation
• Support for weight management
• Management of blood glucose levels
• Promotion of heart health
• Improvement of digestive health

Dosage

Children: Refer to dietary guidelines for children; beans can be introduced as a protein source in appropriate serving sizes based on age and dietary recommendations.

Adults: Refer to dietary guidelines for general consumption; beans can be included in daily meals as a primary protein source, with recommended servings varying based on dietary needs.

Mechanism of action

Beans exert their health benefits primarily through their high fiber content, which can improve digestion and glucose metabolism. They also contain phytochemicals, such as polyphenols and saponins, that may have antioxidant properties and can help reduce inflammation. Additionally, the protein in beans contributes to muscle repair and maintenance.

Pharmacodynamics

The consumption of beans has been associated with a variety of health benefits. Their high fiber content aids in the regulation of blood sugar levels, lowers cholesterol levels, and promotes satiety, which can be beneficial for weight management. The presence of antioxidants in beans helps to combat oxidative stress and inflammation in the body.

Pharmacokinetics

Beans are digested in the gastrointestinal tract, where dietary fibers are fermented by gut microbiota, producing short-chain fatty acids that are beneficial for colon health. The protein undergoes digestion in the stomach and small intestine, with amino acids being absorbed into the bloodstream. The absorption rate may vary depending on the type of bean and preparation method.

Adverse effects

• Gastrointestinal discomfort
• Bloating
• Flatulence
• Allergic reactions in sensitive individuals

Interactions

• May interact with anticoagulants due to high vitamin K content
• Possible interaction with medications affecting blood sugar levels

Precautions

• Use caution in individuals with a history of gastrointestinal disorders
• Monitor for allergic reactions in individuals sensitive to legumes

Pregnancy

Generally considered safe, but excessive consumption should be avoided due to potential effects on digestion.

Breast-feeding

Safe for consumption; however, it may cause gas in infants if consumed in large amounts.

Storage

Store in a cool, dry place away from direct sunlight. Keep in an airtight container to maintain freshness.

Formulations

• Dried beans
• Canned beans
• Bean flour
• Bean protein powder

Indications

• Electrolyte replacement
• Volume expansion in hypovolemic patients
• Management of hyponatremia
• Support in intravenous fluid therapy

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients, as dosages may vary based on the formulation and clinical condition.

Adults: Refer to specific product information or clinical guidelines for dosage recommendations, as disodium is often part of combination products.

Mechanism of action

Disodium compounds often function by providing sodium ions that are essential for various physiological processes. Sodium ions play a critical role in maintaining osmotic balance, nerve impulse transmission, and muscle contraction. In the context of intravenous solutions, disodium helps to restore electrolyte balance in patients.

Pharmacodynamics

The pharmacodynamics of disodium is primarily related to its role in electrolyte balance and fluid homeostasis. Sodium ions are vital for the function of excitable tissues, including neurons and muscle cells. Changes in sodium levels can affect blood pressure, hydration status, and overall cellular function.

Pharmacokinetics

The pharmacokinetics of disodium compounds depend on their specific formulation and route of administration. When administered intravenously, disodium is rapidly distributed in the extracellular fluid, where it helps to maintain osmotic pressure. Sodium is primarily excreted by the kidneys, and its levels can be influenced by fluid intake, dietary sodium, and renal function.

Pregnancy

Use with caution. Consult a healthcare provider for specific guidance.

Breast-feeding

Use with caution. Consult a healthcare provider for specific guidance.

Storage

Store at room temperature, away from moisture and direct sunlight.

Indications

• Lead poisoning
• Mercury poisoning
• Calcium overload
• Certain diagnostic procedures involving heavy metals

Dosage

Children: Refer to the BNF for Children for appropriate dosing information tailored for paediatric patients.

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated, considering factors such as the severity of metal poisoning and renal function.

Mechanism of action

Edetate functions by forming stable complexes with divalent and trivalent metal ions, including lead and calcium, through its multiple carboxylate and amine groups. This chelation renders the metals more soluble and promotes their renal excretion, thereby reducing their toxic effects in the body.

Pharmacodynamics

The chelation of metals by edetate decreases the free metal concentration in the bloodstream, which mitigates the toxic effects associated with heavy metal accumulation. The efficacy of edetate in removing metals such as lead has been well documented, and its ability to bind calcium can influence calcium homeostasis in certain clinical scenarios.

Pharmacokinetics

Edetate is administered intravenously, with rapid distribution throughout the extracellular fluid. It is primarily excreted unchanged by the kidneys. The onset of action occurs quickly after administration, and the duration depends on the dose and the patient's renal function. The elimination half-life is approximately 1 hour but may vary based on renal clearance.

Contra-indications

• Hypersensitivity to edetate or any component of the formulation
• Severe renal impairment
• Active bleeding disorders

Adverse effects

• Hypocalcemia
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Rash
• Fever

Interactions

• May enhance the effects of anticoagulants
• Concurrent use with calcium supplements may reduce effectiveness
• May interfere with the absorption of certain medications due to changes in gastrointestinal motility

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolyte levels, particularly calcium, during treatment
• Assess the patient's hydration status before administration

Pregnancy

Limited data on the use of edetate in pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised as it is not known whether edetate is excreted in human milk. Weigh the risks and benefits before use.

Storage

Store in a cool, dry place, protected from light. Do not freeze.

Formulations

• Edetate disodium injection
• Edetate calcium disodium injection

Dosage

Children: Refer to the BNF for Children for appropriate dosing information in paediatric cases, especially in instances of overdose.

Adults: Refer to the BNF for specific dosing information based on clinical circumstances, particularly in cases of overdose.

Mechanism of action

Ethylene glycol is metabolized by alcohol dehydrogenase to glycoaldehyde, which is subsequently converted to glycolic, glyoxylic, and oxalic acids. These metabolites contribute to anion gap metabolic acidosis and are responsible for tissue injury through the formation of insoluble calcium oxalate crystals.

Pharmacodynamics

The toxicity of ethylene glycol arises from its metabolites, particularly glycolic and oxalic acids. These compounds induce metabolic acidosis, lead to renal failure through calcium oxalate crystal deposition in the kidneys, and can cause neurological impairment. The anion gap increases due to the accumulation of these acids, leading to complications such as cardiovascular instability and potential multi-organ failure.

Pharmacokinetics

Ethylene glycol is rapidly absorbed after oral ingestion. It undergoes first-pass metabolism primarily in the liver, where it is converted into its toxic metabolites. The elimination half-life of ethylene glycol varies but is generally prolonged in cases of renal impairment. Renal excretion of metabolites contributes to the duration of toxicity, necessitating prompt medical intervention in cases of overdose.

Adverse effects

• Metabolic acidosis
• Renal failure
• CNS depression
• Hypocalcemia
• Cardiovascular collapse
• Pulmonary edema

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of metabolic acidosis
• Evaluate electrolyte levels, particularly calcium

Pregnancy

There is limited data on the safety of ethylene glycol in pregnancy. It should only be used if clearly needed.

Breast-feeding

It is unknown if ethylene glycol is excreted in human milk. Caution is advised.

Storage

Store in a tightly closed container at room temperature, away from heat and moisture.

Formulations

• Liquid

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Cholesterol management
• Cognitive support
• Liver health
• Emulsification in food products

Dosage

Children: Refer to the BNF for Children for specific dosing information as it may vary based on the formulation and indication.

Adults: Refer to the BNF for specific dosing information as it may vary based on the formulation and indication.

Mechanism of action

Lecithin serves as a source of phosphatidylcholine, a key component of cell membranes. It facilitates the transport of fats and cholesterol in the body, enhancing lipid metabolism. Additionally, phosphatidylcholine is involved in the synthesis of acetylcholine, a neurotransmitter important for memory and muscle function.

Pharmacodynamics

Lecithin has been shown to influence lipid metabolism, potentially lowering serum cholesterol levels and improving liver function. By serving as an emulsifying agent, it helps to increase the bioavailability of fat-soluble vitamins and other nutrients. Its role in cell membrane integrity supports overall cellular function and health.

Pharmacokinetics

Lecithin is absorbed in the gastrointestinal tract and metabolized in the liver. It is distributed throughout the body, where it is incorporated into cell membranes. The half-life of lecithin is not well-defined due to its nature as a dietary compound, but its components, such as phosphatidylcholine, are rapidly utilized by the body.

Pregnancy

Lecithin may be used during pregnancy, but it is essential to consult a healthcare provider before use.

Breast-feeding

Lecithin is generally considered safe while breastfeeding; however, it is advisable to seek medical advice.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Fatty acid supplementation
• Dietary management of hyperlipidemia
• Support in lipid metabolism disorders

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Oleate functions as a signaling molecule that can influence various metabolic pathways, including phospholipid remodeling and choline biosynthesis. It is involved in the regulation of cellular functions through its incorporation into phospholipids and modulation of enzyme activity, particularly phospholipases.

Pharmacodynamics

Oleate exhibits effects on lipid metabolism, insulin sensitivity, and inflammation. It has been shown to influence the composition of cell membranes, affecting their fluidity and functionality. Oleate may also play a role in the regulation of gene expression related to fat metabolism and inflammation.

Pharmacokinetics

Oleate is absorbed through the gastrointestinal tract and transported in the bloodstream as part of lipoproteins. It is metabolized primarily in the liver and can be oxidized for energy production or esterified for storage in adipose tissue. The metabolism of oleate can influence the levels of other fatty acids and lipid profiles in the body.

Pregnancy

Oleate is generally considered safe during pregnancy; however, it is advisable to consult a healthcare professional before use.

Breast-feeding

Oleate is typically regarded as safe during breastfeeding, but it is important to seek guidance from a healthcare provider.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Oleate solution
• Oleate emulsion

Indications

• Management of menopausal symptoms
• Cardiovascular health improvement
• Cholesterol reduction
• Dietary protein source
• Potential role in cancer prevention

Dosage

Children: Refer to specific dietary guidelines and recommendations for children, as soya products can be part of a balanced diet.

Adults: Refer to specific dietary guidelines as soya is primarily consumed as a food source rather than a pharmacological agent.

Mechanism of action

Soya exerts its effects primarily through its isoflavones, which are phytoestrogens that can bind to estrogen receptors in the body. This action can modulate estrogen activity, leading to various physiological effects, such as alleviating menopausal symptoms and influencing lipid metabolism. Additionally, the protein in soya can help lower cholesterol levels and improve cardiovascular health by enhancing endothelial function and reducing inflammation.

Pharmacodynamics

The pharmacodynamics of soya is largely attributed to its isoflavone content, including genistein and daidzein. These compounds can mimic estrogen and may exert both estrogenic and anti-estrogenic effects depending on the tissue type. The consumption of soya has been associated with improvements in lipid profiles, reductions in blood pressure, and potential protective effects against certain cancers, particularly hormone-dependent cancers.

Pharmacokinetics

The bioavailability of isoflavones from soya varies but is generally well-absorbed following consumption. After ingestion, isoflavones undergo extensive metabolism in the liver and intestines, leading to the formation of various metabolites that can be detected in the plasma. The elimination half-life of these metabolites varies, but they are typically cleared from the body within hours to a few days, depending on individual metabolism and the amount consumed.

Contra-indications

• Hypersensitivity to soya or any of its components
• Severe soy allergy

Adverse effects

• Gastrointestinal discomfort
• Nausea
• Diarrhea
• Allergic reactions, including rash and itching
• Headache
• Fatigue

Interactions

• May interact with anticoagulants, increasing bleeding risk
• Potential interaction with thyroid medications, affecting thyroid hormone levels

Precautions

• Use with caution in individuals with a history of allergic reactions to legumes
• Monitor for possible hormonal effects in individuals with hormone-sensitive conditions

Pregnancy

Soya is generally considered safe in moderation during pregnancy, but high doses should be avoided due to potential hormonal effects.

Breast-feeding

Soya is usually considered safe during breastfeeding, but excessive consumption should be avoided as effects on infants are not fully understood.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Soybeans (whole or processed)
• Soy milk
• Soy protein isolate
• Soy flour
• Soy lecithin

Mechanism of action

The action of propofol involves a positive modulation of the inhibitory function of the neurotransmitter gama-aminobutyric acid (GABA) through GABA-A receptors.

Pharmacodynamics

Propofol is a sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation, usually within 40 seconds from the start of an injection (the time for one arm-brain circulation).

Mechanism of action

Ethylene glycol is metabolized by alcohol dehydrogenase to glycoaldehyde, which is then metabolized to glycolic, glyoxylic, and oxalic acids. These acids, along with excess lactic acid are responsible for the anion gap metabolic acidosis. Oxalic acid readily precipitates with calcium to form insoluble calcium oxalate crystals. Tissue injury is caused by widespread deposition of oxalate crystals and the toxic effects of glycolic and glyoxylic acids.